EA200501582A1 - Получение и очистка синтетического капсаицина - Google Patents

Получение и очистка синтетического капсаицина

Info

Publication number
EA200501582A1
EA200501582A1 EA200501582A EA200501582A EA200501582A1 EA 200501582 A1 EA200501582 A1 EA 200501582A1 EA 200501582 A EA200501582 A EA 200501582A EA 200501582 A EA200501582 A EA 200501582A EA 200501582 A1 EA200501582 A1 EA 200501582A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining
capsaicin
synthetic capsaicin
cleaning synthetic
cleaning
Prior art date
Application number
EA200501582A
Other languages
English (en)
Other versions
EA008705B1 (ru
Inventor
Шэрон Маклвейн
Вей Чен
Премчандран Х. Рамия
Рональд Берч
Ричард Б. Картер
Тимоти Э. Андерсон
Хэпин Чжан
Original Assignee
Алгоркс Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алгоркс Фармасьютикалз, Инк. filed Critical Алгоркс Фармасьютикалз, Инк.
Publication of EA200501582A1 publication Critical patent/EA200501582A1/ru
Publication of EA008705B1 publication Critical patent/EA008705B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

В настоящем изобретении предложен способ синтеза трансизомера капсаицина и/или капсаициноподобных соединений путем использования процесса, в котором трансконфигурацию задают с самого начала реакции синтеза и сохраняют ее на протяжении всего процесса синтеза.
EA200501582A 2003-04-08 2004-04-08 Получение и очистка синтетического капсаицина EA008705B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46116403P 2003-04-08 2003-04-08
US53107403P 2003-12-18 2003-12-18
PCT/US2004/010745 WO2004092122A2 (en) 2003-04-08 2004-04-08 Preparation and purification of synthetic capsaicin

Publications (2)

Publication Number Publication Date
EA200501582A1 true EA200501582A1 (ru) 2006-06-30
EA008705B1 EA008705B1 (ru) 2007-06-29

Family

ID=33303038

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501582A EA008705B1 (ru) 2003-04-08 2004-04-08 Получение и очистка синтетического капсаицина

Country Status (10)

Country Link
US (2) US20050085652A1 (ru)
EP (1) EP1615880A4 (ru)
JP (1) JP2006522815A (ru)
AU (1) AU2004230915B2 (ru)
BR (1) BRPI0409748A (ru)
CA (1) CA2521925A1 (ru)
EA (1) EA008705B1 (ru)
MX (1) MXPA05010882A (ru)
NZ (1) NZ542887A (ru)
WO (1) WO2004092122A2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020690A1 (en) 2002-12-18 2005-01-27 Algorx Infiltration of capsaicin into surgical sites and open wounds
US20040191338A1 (en) * 2002-12-18 2004-09-30 Algorx Administration of capsaicinoids
AU2004230915B2 (en) * 2003-04-08 2008-08-07 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
EP1610742B1 (en) 2003-04-10 2015-01-21 Neurogesx, Inc. Uses and compositions for administration of capsaicin
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
CN100410235C (zh) * 2006-06-15 2008-08-13 山东省科学院生物研究所 辣椒碱的化学合成与纯化方法
ITMI20071603A1 (it) * 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata
DK2453858T3 (da) * 2009-07-16 2014-11-03 Brightwake Ltd Fremgangsmåde
PT2629610T (pt) 2010-07-27 2017-11-24 Flex Pharma Inc Métodos e composições para prevenção e alívio de cãibras musculares e para recuperação de irritabilidade e fadiga neuromuscular após exercício
AU2013341380B2 (en) 2012-11-12 2018-04-26 Propella Therapeutics, Inc. Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid
US20150133561A1 (en) 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
US11253493B2 (en) 2017-01-23 2022-02-22 Cliff-Cartwright Corporation Compositions and methods affecting exercise performance
AU2019403441A1 (en) * 2018-12-21 2021-06-10 Vivasor, Inc. Perineural administration of resiniferatoxin for treatment of maladaptive pain
CN110453311A (zh) * 2019-09-23 2019-11-15 浙江理工大学 一种温感壳聚糖纤维及其制备方法
NO20200333A1 (en) * 2020-03-20 2021-03-29 Axichem As Synthesis of capsaicin derivatives
CN115850108B (zh) * 2022-12-14 2024-10-01 中国烟草总公司郑州烟草研究院 17-羟基辣椒素及其标记物的合成方法
CN117770450B (zh) * 2024-02-23 2024-06-21 天津福来特新材料科技有限公司 一种高纯度的辣椒素组合物及其制备方法和其应用

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51113835A (en) * 1975-03-28 1976-10-07 San Ei Chem Ind Ltd Preparation of capsaicine and homologues
NL185194C (nl) * 1976-07-27 1990-02-16 Naarden International Nv Werkwijze voor de bereiding van reukstofcomposities, alsmede werkwijze voor de bereiding van een reukstof.
US4313958A (en) * 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
US4443473A (en) * 1981-06-30 1984-04-17 The Procter & Gamble Company Carbamate derivatives
US4460602A (en) * 1981-06-30 1984-07-17 The Procter & Gamble Company Urea derivatives
US4401663A (en) * 1981-06-30 1983-08-30 The Procter & Gamble Company Novel sulfonamide derivatives
IT1211092B (it) * 1981-08-14 1989-09-29 Montedison Spa Dieteri dell'alcool 4-idrossi-benzi lico
US4424205A (en) * 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
US4536404A (en) * 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
JPS6054336A (ja) * 1983-09-05 1985-03-28 Agency Of Ind Science & Technol ８−メチル−トランス−６−ノネン酸の製造方法
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPS63188652A (ja) * 1987-01-22 1988-08-04 T Hasegawa Co Ltd ５−ヒドロキシ−２−アルキン酸エステルの製法
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US4939149A (en) * 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5134166A (en) * 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US5021450A (en) * 1989-05-30 1991-06-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5383848A (en) * 1990-04-12 1995-01-24 Gensia, Inc. Iontophoretic administration of drugs
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
US5232684A (en) * 1990-06-29 1993-08-03 The United States Of America As Represented By The Department Of Health And Human Services Labelled resiniferatoxin, compositions thereof, and methods for using the same
US5094782A (en) * 1990-12-24 1992-03-10 National Science Council Of Republic Of China Synthesis of capsacin derivatives and their use as an analgesic drug and vessel dilation drug
US5178879A (en) * 1992-04-17 1993-01-12 Michael Adekunle Capsaicin gel
US5431914A (en) * 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US6593371B1 (en) * 1993-05-19 2003-07-15 Jeff J. Staggs Treatment for wart and related disorders
US6063381A (en) * 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US5910512A (en) * 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
JPH07291904A (ja) * 1994-04-28 1995-11-07 Nippon Saafuakutanto Kogyo Kk 天然型のスフィンゴシン及びその類縁化合物の製造法
US5660830A (en) * 1994-09-14 1997-08-26 Anderson; Cleve Richard Solubilizing counter-irritants and concurrently extracting capsaicin from the same specific peppers
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US5756107A (en) * 1994-12-21 1998-05-26 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5788982A (en) * 1995-06-16 1998-08-04 Nadoolman; Wolffe Method and composition for treating oral pain using capsaicin
US5882663A (en) * 1995-10-20 1999-03-16 Koeniger; Erich A. Topical pain-relieving preparation containing C12 To C18 isoparaffins
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) * 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5874420A (en) * 1995-12-26 1999-02-23 Allegheny University Of The Health Sciences Process for regulating vagal tone
US5869533A (en) * 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
US5856361A (en) * 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
US5716621A (en) * 1996-07-03 1998-02-10 Pharmadyn, Inc. Nonocclusive drug delivery device and process for its manufacture
US6060060A (en) * 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
US6201022B1 (en) * 1997-03-27 2001-03-13 Myorx, Inc. Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid
WO1998053825A1 (en) * 1997-05-27 1998-12-03 Algos Pharmaceutical Corporation Analgesic drug composition containing a capsaicinoid and potentiator therefor
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
WO1999001114A1 (en) * 1997-07-02 1999-01-14 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
US6063758A (en) * 1997-07-09 2000-05-16 Advanced Targeting Systems, Inc. Substance P-Saporin (SP-SAP) conjugates and methods of use thereof
JP3133708B2 (ja) * 1997-07-18 2001-02-13 アルプス薬品工業株式会社 カプサイシンの工業的精製方法
CA2298540A1 (en) * 1997-08-20 1999-02-25 David J. Julius Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
EP0906757B1 (en) * 1997-09-16 2005-05-11 Solvay Pharmaceuticals GmbH Analgesic composition comprising moxonidine and an opioid analgesic agent
US5891919A (en) * 1997-09-19 1999-04-06 Burlington Bio-Medical & Scientific Corp. Denatonium capsaicinate and methods of producing the same
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
KR20060085258A (ko) * 1998-02-24 2006-07-26 웨이크 포리스트 유니버시티 만성 통증 및 여성에 특유한 통증을 비롯한 통증의 치료방법
DE19807908A1 (de) * 1998-02-25 1999-08-26 Basf Ag Kosmetisches Mittel
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6235788B1 (en) * 1998-09-21 2001-05-22 James M. Terry Method for treating pre-malignant basal and squamous cell lesions of the epithelium
JP3211027B2 (ja) * 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
US6572871B1 (en) * 1999-01-06 2003-06-03 W. Edward Church Pain treatment method and apparatus using heating wrap and analgesic cream
CA2267049A1 (en) * 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Pharmaceutical compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020035157A1 (en) * 1999-03-30 2002-03-21 Mccleane Gary Pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US6197823B1 (en) * 1999-09-29 2001-03-06 Medical Merchandising, Inc. Pain reliever and method of use
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
US6573302B1 (en) * 1999-09-29 2003-06-03 Medical Merchandising, Inc. Cream utilizing capsaicin
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6780443B1 (en) * 2000-02-04 2004-08-24 Takasago International Corporation Sensate composition imparting initial sensation upon contact
US6596266B2 (en) * 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US6689399B1 (en) * 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
AU8066701A (en) * 2000-07-20 2002-02-05 Neurogen Corp Capsaicin receptor ligands
US20040146590A1 (en) * 2001-03-22 2004-07-29 Iadarola Michael J Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
US6634523B2 (en) * 2001-04-06 2003-10-21 Summithood Enterprises, Llc Pepper agent system
US20040138239A1 (en) * 2001-08-23 2004-07-15 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20030104085A1 (en) * 2001-12-05 2003-06-05 Yeomans David C. Methods and compositions for treating back pain
JP3951008B2 (ja) * 2002-01-17 2007-08-01 国立大学法人 岡山大学 カプサイシン分解合成酵素及びその生産方法
WO2003062209A2 (en) * 2002-01-17 2003-07-31 Neurogen Corporation Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
US20030157185A1 (en) * 2002-02-08 2003-08-21 Lou Paradise Topical treatment of neuropathy
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
EP1539124B1 (en) * 2002-09-05 2018-07-18 Vanderbilt Royalty Sub L.P. Compositions and kits for the removal of irritating compounds from bodily surfaces
US20040058734A1 (en) * 2002-09-24 2004-03-25 Williams Trevor Grey Flexible rotational drive coupling device
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US20040191338A1 (en) * 2002-12-18 2004-09-30 Algorx Administration of capsaicinoids
US20050020690A1 (en) * 2002-12-18 2005-01-27 Algorx Infiltration of capsaicin into surgical sites and open wounds
US20040146464A1 (en) * 2003-01-23 2004-07-29 Bernstein Joel E. Compositions and method for daily tooth and gum care
AU2004230915B2 (en) * 2003-04-08 2008-08-07 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения

Also Published As

Publication number Publication date
NZ542887A (en) 2008-05-30
MXPA05010882A (es) 2005-11-25
AU2004230915A1 (en) 2004-10-28
EP1615880A2 (en) 2006-01-18
BRPI0409748A (pt) 2006-10-24
JP2006522815A (ja) 2006-10-05
US20050085652A1 (en) 2005-04-21
AU2004230915B2 (en) 2008-08-07
CA2521925A1 (en) 2004-10-28
WO2004092122A3 (en) 2005-12-29
US20070293703A1 (en) 2007-12-20
EP1615880A4 (en) 2007-03-07
EA008705B1 (ru) 2007-06-29
WO2004092122A2 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
EA200501582A1 (ru) Получение и очистка синтетического капсаицина
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
GB2446084A (en) Synthesis of four color 3-o-allyl modified photocleavable fluorescent nucleotides and related methods
DE602006007612D1 (de) Verfahren und zwischenprodukte zur synthese des caspofungins
DE602005023429D1 (de) Verfahren zur festphasen-peptidsynthese
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE602006021580D1 (de) Verfahren zur synthese codierter bibliotheken
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
ATE480525T1 (de) Neues verfahren zur synthese von 2- aminooxazolverbindungen
EA200401551A1 (ru) Получение сульфинилацетамида
DE602004014321D1 (de) Neue synthese von irbesartan
MY143266A (en) New process for synthesizing (7-methoxy-3,4-dihydro-1-naphthalenyl)acetonitrile and its application in the synthesis of agomelatine
ATE425121T1 (de) Verfahren zur umwandlung von polysulfanen
HK1079513A1 (en) Process for preparing intermediates
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
ITMI20020991A0 (it) Procedimento per la sintesi del modafinil
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
ATE440848T1 (de) Synthese von proteaseinhibitorvorstufen
DE60336986D1 (de) Verfahren zur herstellung von biarylverbindungen
WO2006079112A3 (en) Enantioselective synthesis of merrilactone a and its analogs
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
DE60323991D1 (de) Verfahren zur herstellung von aldehydverbindungen
DE60329721D1 (de) Regiospezifische synthese von nikotinderivaten
DE10295581D2 (de) Verfahren zur Synthese von All-D-Peptiden

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU